Psoriatic Arthropathy NewsLatest News On Psoriatic Arthropathy Sonelokimab Yields Significant Improvements in Active PsA in Early Trial53 minutes ago TYK2 Inhibitor Shows Early Promise in Psoriatic Arthritis21 hours ago Phase 3 Trial Supports Ixekizumab in Treatment of Juvenile PsA, Enthesitis-Related Arthritis6/20/2024 2:54 AM FDA Approves Risankizumab for Ulcerative Colitis6/19/2024 11:15 AM Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial6/19/2024 6:53 AM Psoriatic Arthritis Drugs Comparably Improve Outcomes Across the Board6/19/2024 4:40 AM Clinical Characteristics May Affect Biologic Treatment Outcomes in Psoriasis6/18/2024 9:36 AM What's in a Name: Defining Difficult-to-Treat axSpA and PsA6/14/2024 7:57 AM EULAR 2024 Preview: What's Not to Miss at This Year's Congress?6/10/2024 2:28 PM Medicare Part D Plans Poorly Cover Adalimumab Biosimilars6/6/2024 9:53 AM FDA Extends Upadacitinib Indications to Children With Arthritis6/4/2024 3:51 PM Maintenance Treatment With Guselkumab for Ulcerative Colitis Meets All Endpoints: QUASAR5/22/2024 6:39 AM FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo5/2/2024 11:04 AM Two Biosimilars Approved in Europe for Autoimmune Disorders4/26/2024 10:17 AM FDA Approves Second Ustekinumab Biosimilar4/17/2024 5:01 PM Guselkumab Provides Long-Term Relief From Psoriatic Arthritis Symptoms4/17/2024 1:32 AM Worldwide Prevalence of Psoriatic Arthritis: Meta-Analysis Sheds Light4/12/2024 5:41 AM Congress Allocates $10 Million for Arthritis Research4/8/2024 2:18 AM